1. |
Wenqi D, Li W, Shanshan C, et al. EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer[J]. J Cancer Res Clin Oncol, 2009, 135(9): 1277-1285.
|
2. |
Zhou H, Tang Y, Liang X, et al. RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo[J]. Int J Cancer, 2009, 125(2): 453-462.
|
3. |
Kanwar JR, Kamalapuram SK, Kanwar RK. Targeting survivin in cancer: patent review[J]. Expert Opin Ther Pat, 2010, 20(12): 1723-1737.
|
4. |
Chen T, Deng C. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells[J]. Int Immunopharmacol, 2008, 8(7): 1006-1011.
|
5. |
Li SD, Huang L. Nonviral is superior to viral gene delivery[J]. J Control Release, 2007, 123(3): 181-183.
|
6. |
王青松, 方晓玲. 非病毒载体在肿瘤基因治疗领域的研究进展[J]. 药物生物技术, 2005, 12(2): 125-129.
|
7. |
Lungwitz UT. Polyethylenimine-based non-viral gene delivery systems[J]. Eur J Pharm Biopharm, 2005, 60(2): 247-266.
|
8. |
Han S, Mahato RI, Sung YK, et al. Development of biomaterials for gene therapy[J]. Mol Ther, 2000, 2(4): 302-317.
|
9. |
Fornari F, Gramantieri L, Ferracin M, et al. MiR-221 con-trols CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma[J]. Oncogene, 2008, 27(43): 5651-5661.
|
10. |
Gandellini P, Folini M, Bandiera R, et al. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment[J]. Biochem Pharmacol, 2007, 73(11): 1703-1714.
|
11. |
Li J, Piao YF, Jiang Z, et al. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice[J]. World J Gastroenterol, 2009, 15(21): 2602-2608.
|
12. |
Huang C, Jiang T, Zhu L, et al. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo[J]. Int J Oncol, 2011, 38(6): 1637-1644.
|
13. |
De Souza Nascimento P, Alves G, Fiedler W. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells[J]. Oncol Rep, 2006, 16(2): 423-428.
|
14. |
Lin C, Engbersen JF. The role of the disulfide group in disulfide-based polymeric gene carriers[J]. Expert Opin Drug Deliv, 2009, 6(4): 421-439.
|
15. |
Liu J, Jiang X, Xu L, et al. Novel reduction-responsive cross-linked polyethylenimine derivatives by click chemistry for nonviral gene delivery[J]. Bioconjug Chem, 2010, 21(10): 1827-1835.
|
16. |
Choi S, Lee KD. Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate[J]. J Control Release, 2008, 131(1): 70-76.
|
17. |
Breunig M, Lungwitz U, Liebl R, et al. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery[J]. Proc Natl Acad Sci U S A, 2007, 104(36): 14454-14459.
|
18. |
Lin C, Blaauboer CJ, Timoneda MM, et al. Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery[J]. J Control Release, 2008, 126(2): 166-174.
|
19. |
Piest M, Lin C, Mateos-Timoneda MA, et al. Novel poly(amido amine)s with bioreducible disulfide linkages in their diamino-units: structure effects and in vitro gene transfer properties[J]. J Control Release, 2008, 130(1): 38-45.
|
20. |
Piest M, Engbersen JF. Role of boronic acid moieties in poly(amido amine)s for gene delivery[J]. J Control Release, 2011, 155(2): 331-340.
|